Strides Arcolab’s arm receives US FDA approval for Zoledronic Acid

06 Mar 2013 Evaluate

Agila Specialties, a wholly owned subsidiary of Strides Arcolab has received ANDA approval for Zoledronic Acid Injection 4 mg (base)/ 5ml packaged in Single dose vials. Zoledronic Acid is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer.

According to IMS data, the US market for Zoledronic Acid 5ML is approximately $520 million. The product is expected to be launched shortly.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

942.00 -8.50 (-0.89%)
05-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1568.85
Dr. Reddys Lab 6536.00
Cipla 1509.40
Zydus Lifesciences 1162.40
Lupin 1769.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.